BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Krajcovicova A, Hlavaty T, Killinger Z, Miznerova E, Toth J, Letkovsky J, Nevidanska M, Cierny D, Koller T, Zelinkova Z, Huorka M, Payer J. Combination therapy with an immunomodulator and anti-TNFα agent improves bone mineral density in IBD patients. J Crohns Colitis 2014;8:1693-701. [PMID: 25175812 DOI: 10.1016/j.crohns.2014.08.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Merlotti D, Mingiano C, Valenti R, Cavati G, Calabrese M, Pirrotta F, Bianciardi S, Palazzuoli A, Gennari L. Bone Fragility in Gastrointestinal Disorders. Int J Mol Sci 2022;23:2713. [PMID: 35269854 DOI: 10.3390/ijms23052713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Baban YN, Edicheria CM, Joseph J, Kaur P, Mostafa JA. Osteoporosis Complications in Crohn's Disease Patients: Factors, Pathogenesis, and Treatment Outlines. Cureus 2021. [DOI: 10.7759/cureus.20564] [Reference Citation Analysis]
3 Yu J, Xia Y, Wang G, Xiong Z, Zhang H, Lai PF, Song X, Ai L. Anti-osteoporotic potential of Lactobacillus plantarum AR237 and AR495 in ovariectomized mice. Journal of Functional Foods 2021;87:104762. [DOI: 10.1016/j.jff.2021.104762] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Ebeling PR, Nguyen HH, Aleksova J, Vincent AJ, Wong P, Milat F. Secondary Osteoporosis. Endocr Rev 2021:bnab028. [PMID: 34476488 DOI: 10.1210/endrev/bnab028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
5 Olic Akrapovic I, Radic M, Tonkic A. Is there higher percentage of undetected osteopenia and osteoporosis among patients with ulcerative colitis in Saudi Arabia? World J Gastroenterol 2021; 27(27): 4481-4483 [PMID: 34366618 DOI: 10.3748/wjg.v27.i27.4481] [Reference Citation Analysis]
6 Talotta R, Rucci F, Scaglione F. Calcium physiology, metabolism and supplementation: a glance at patients with ankylosing spondylitis. Reumatologia 2020;58:297-311. [PMID: 33227082 DOI: 10.5114/reum.2020.100112] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ratajczak AE, Rychter AM, Zawada A, Dobrowolska A, Krela-Kaźmierczak I. Nutrients in the Prevention of Osteoporosis in Patients with Inflammatory Bowel Diseases. Nutrients 2020;12:E1702. [PMID: 32517239 DOI: 10.3390/nu12061702] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
8 Sonato C, Pepe J, Colangelo L, Biondi P, Occhiuto M, Cipriani C, Minisola S. Osteoporosi secondarie. L'Endocrinologo 2020;21:39-41. [DOI: 10.1007/s40619-020-00707-1] [Reference Citation Analysis]
9 Hoffmann P, Krisam J, Kasperk C, Gauss A. Prevalence, Risk Factors and Course of Osteoporosis in Patients with Crohn's Disease at a Tertiary Referral Center. J Clin Med 2019;8:E2178. [PMID: 31835600 DOI: 10.3390/jcm8122178] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
10 van Bodegraven AA, Bravenboer N. Perspective on skeletal health in inflammatory bowel disease. Osteoporos Int 2020;31:637-46. [PMID: 31822927 DOI: 10.1007/s00198-019-05234-w] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
11 Morgan S, Hooper KM, Milne EM, Farquharson C, Stevens C, Staines KA. Azathioprine Has a Deleterious Effect on the Bone Health of Mice with DSS-Induced Inflammatory Bowel Disease. Int J Mol Sci 2019;20:E6085. [PMID: 31816823 DOI: 10.3390/ijms20236085] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
12 Deuring JJ, Li M, Cao W, Chen S, Wang W, de Haar C, van der Woude CJ, Peppelenbosch M. Pregnane X receptor activation constrains mucosal NF-κB activity in active inflammatory bowel disease. PLoS One 2019;14:e0221924. [PMID: 31581194 DOI: 10.1371/journal.pone.0221924] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
13 Miranda-Bautista J, Verdejo C, Díaz-Redondo A, Bretón I, Bellón JM, Pérez-Valderas MD, Caballero-Marcos A, de Dios-Lascuevas M, González-Río E, García-Sánchez C, Marín-Jiménez I, Bañares R, Menchén L. Metabolic bone disease in patients diagnosed with inflammatory bowel disease from Spain. Therap Adv Gastroenterol 2019;12:1756284819862152. [PMID: 31391867 DOI: 10.1177/1756284819862152] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
14 Colangelo L, Biamonte F, Pepe J, Cipriani C, Minisola S. Understanding and managing secondary osteoporosis. Expert Rev Endocrinol Metab 2019;14:111-22. [PMID: 30735441 DOI: 10.1080/17446651.2019.1575727] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
15 Bryant RV, Schultz CG, Ooi S, Goess C, Costello SP, Vincent AD, Schoeman SN, Lim A, Bartholomeusz FD, Travis SPL, Andrews JM. Obesity in Inflammatory Bowel Disease: Gains in Adiposity despite High Prevalence of Myopenia and Osteopenia. Nutrients. 2018;10. [PMID: 30200405 DOI: 10.3390/nu10091192] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
16 Krajcovicova A, Kuzma M, Hlavaty T, Hans D, Koller T, Jackuliak P, Leskova Z, Sturdik I, Killinger Z, Payer J. Decrease of trabecular bone score reflects severity of Crohn's disease: results of a case-control study. Eur J Gastroenterol Hepatol 2018;30:101-6. [PMID: 29064848 DOI: 10.1097/MEG.0000000000000997] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
17 Dai SX, Gu HX, Lin QY, Huang SZ, Xing TS, Zhang QF, Wu G, Chen MH, Tan WE, Jian HJ, Zheng ZW, Zhong T, Zhang MH, Cheng XF, Huang P, Liao GJ, Sha WH. CD8(+)CD28(+)/CD8(+)CD28(-) T cell equilibrium can predict the active stage for patients with inflammatory bowel disease. Clin Res Hepatol Gastroenterol 2017;41:693-702. [PMID: 28502591 DOI: 10.1016/j.clinre.2017.03.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
18 Castro B, Rivero M, Crespo J, Riancho JA, Valero C. Influence of anti-TNF therapy on bone metabolism in patients with inflammatory bowel disease. European Journal of Internal Medicine 2017;39:e33-4. [DOI: 10.1016/j.ejim.2017.01.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
19 Raghu Subramanian C, Triadafilopoulos G. Care of inflammatory bowel disease patients in remission. Gastroenterol Rep (Oxf) 2016;4:261-71. [PMID: 27899522 DOI: 10.1093/gastro/gow032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
20 Sales-Campos H, de Souza PR, Basso PJ, Nardini V, Silva A, Banquieri F, Alves VB, Chica JE, Nomizo A, Cardoso CR. Amelioration of experimental colitis after short-term therapy with glucocorticoid and its relationship to the induction of different regulatory markers. Immunology 2017;150:115-26. [PMID: 27618667 DOI: 10.1111/imm.12672] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]